Table 1. General characteristics of the study population.
(N = 111) | |
Male [n(%)] | 67 (60%) |
Age (years) | 57±11.38 |
Black [n(%)] | 21 (19%) |
Follow up time (months) | 21 (9–55) |
Diabetes [n(%)] | 27 (24%) |
Tobacco use [n(%)] | 57 (51%) |
Body mass index (kg/m2) | 26.8±5.26 |
Creatinine (mg/dL) | 2.26±0.84 |
eGFR (ml/min/1,73 m2) | 34.7±16.1 |
Proteinuria (g/24 h) | 0.24 (0–0.79) |
Hemoglobin (g/dL) | 12.7±1.8 |
Potassium (mEq/L) | 4.7 (4.3–5.1) |
Magnesium (mEq/L) | 1.9 (1.7–2.1) |
Ionized calcium (mmol/L) | 1.28±0.05 |
Phosphate (mg/dL) | 3.78±0.72 |
Alkaline phosphatase (mg/dl) | 81 (66–103) |
PTH (pg/ml) | 110 (63–193) |
iFGF 23 (pg/ml) | 47.3 (23.2–102.8) |
CRP (mg/dl) | 0.28 (0.12–0.77) |
IL6 (pg/ml) | 4.6 (2.7–8.4) |
Total cholesterol (mg/dL) | 184.2±37.7 |
LDL cholesterol (mg/dL) | 101±28.2 |
HDL cholesterol (mg/dL) | 51.5±14.3 |
Triglycerides (mg/dL) | 125 (99–206) |
Median systolic pressure (mmHg) | 125 (116.7–137) |
Mean diastolic pressure (mmHg) | 78.6±10.9 |
Absence of systolic decency [n(%)] | 32 (29%) |
Non controlled hypertension [n(%)] | 23 (21%) |
Left ventricular mass index (g/m2) | 102.3 (84.4–131.3) |
Ejection fraction (%) | 67 (62–70) |
Calcium score (AU) | 9 (0–334) |
eGFR - estimated Glomerular Filtration Rate; iPTH - intact Parathyroid Hormone; FGF23 - Fibroblast Growth Factor 23; CRP - C-Reactive Protein; IL6 - Interleukin-6. Results in mean ± SD, median (interquartiles) or proportions.